Occurrence of ventricular tachycardia (VT) remains a risk in repaired congenital heart disease (CHD).[@B1][@B2][@B3] We report a case of successful catheter ablation of drug-refractory peri-conduit VT in a patient with Rastelli-type repair using a right ventricle-to-pulmonary artery (RV-PA) conduit. Electroanatomic activation and voltage maps of the RV were created and merged with cardiac CT using the CARTO system v4.3 (Biosense Webster, Diamond Bar, CA, USA) and an open-irrigated tip Thermocool™ catheter (Biosense Webster) ([Fig. 1](#F1){ref-type="fig"}). During electrophysiological study, programmed stimulation induced 2 VTs, including a left bundle branch block morphology with superior and inferior axes (clinical VT, [Fig, 2A](#F2){ref-type="fig"} and [Fig. 2B](#F2){ref-type="fig"}, respectively). Entrainment and/or activation mapping identified the 2 VT circuits sharing a common conduction isthmus localized between the tricuspid annulus (surgical scar) and the RV-PA conduit ([Fig. 2](#F2){ref-type="fig"}). The exit of VT1 was located between the superior tricuspid annulus and RV-PA conduit ([Fig. 3A](#F3){ref-type="fig"}, [Supplementary Video 1](#S1){ref-type="supplementary-material"} in the online-only Data Supplement), while VT2 exited at the anterior RV scar border ([Fig. 3B](#F3){ref-type="fig"}). Radiofrequency energy delivered in a temperature-controlled mode at 35-40 Watts targeting an impedance drop of 10 Ohms at the isthmus, where an isolated late potential was recorded, could not induce VT ([Fig. 3C](#F3){ref-type="fig"}).

Anatomical boundaries and surgical scars contribute to the important substrates for VT arrhythmogenesis in repaired CHD and can be eliminated by ablation. Pre-procedural evaluation of surgical anatomy and image reconstruction provides pivotal information for identifying potential substrates and selecting ablation strategies.[@B4])[@B5]
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Supplementary Material
======================

The online-only Data Supplement is available with article at <https://doi.org/10.4070/kcj.2017.0012>.
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